The fallout from the F.D.A.’s rejection of a new treatment for PTSD worries researchers and experts who fear other psychedelic drugs in the pipeline could be jeopardized.
How an Activist Group Helped Torpedo MDMA Therapy
Written by
in
Clinical Trials, Drugs (Pharmaceuticals), Ethics and Official Misconduct, Food and Drug Administration, Institute for Clinical and Economic Review, Lykos Therapeutics, Mental Health and Disorders, Multidisciplinary Assn for Psychedelic Studies, Post-Traumatic Stress Disorder, Psychedelic and Hallucinogenic Drugs, Psychiatry and Psychiatrists, Psymposia, Regulation and Deregulation of Industry, Research, Therapy and Rehabilitation, Veterans